CITR
Price
$2.42Alerts
Change
-$0.03 (-1.22%)
Updated
Nov 11, 04:50 PM (EDT)
Capitalization
129.9M
Earnings call today
Intraday BUY SELL Signals
FEAM
Price
$1.87Alerts
Change
+$0.06 (+3.31%)
Updated
Nov 11 closing price
Capitalization
79.55M
One day until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CITR vs FEAM

CITR vs FEAM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CITR vs. FEAM commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CITR is a Hold and FEAM is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CITR with price predictions
Nov 10, 2026

CITR's RSI Indicator ascending out of oversold territory

The RSI Oscillator for CITR moved out of oversold territory on November 04, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 18 similar instances when the indicator left oversold territory. In 17 of the 18 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 38 of 44 cases where CITR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.

The Moving Average Convergence Divergence (MACD) for CITR just turned positive on October 15, 2026. Looking at past instances where CITR's MACD turned positive, the stock continued to rise in 40 of 49 cases over the following month. The odds of a continued upward trend are 82%.

Following a +9.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where CITR advanced for three days, in 140 of 166 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

CITR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CITR as a result. In 103 of 107 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CITR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for CITR entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 78 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CITR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.

The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CITR's P/B Ratio (14.948) is slightly higher than the industry average of (2.284). P/E Ratio (0.000) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.548). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (64.935) is also within normal values, averaging (48.960).

The Tickeron Price Growth Rating for this company is 88 (best 1 - 100 worst), indicating slightly worse than average price growth. CITR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for FEAM with price predictions
Nov 10, 2026

FEAM's RSI Indicator stoops into oversold zone

The RSI Oscillator for FEAM moved into overbought territory on November 10, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 19 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where FEAM advanced for three days, in 179 of 222 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

FEAM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FEAM as a result. In 76 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for FEAM turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In 35 of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

FEAM moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for FEAM crossed bearishly below the 50-day moving average on November 03, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FEAM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for FEAM entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.241) is normal, around the industry mean (2.284). P/E Ratio (-1.336) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.548). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (48.960).

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. FEAM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FEAM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

FUNDAMENTALS RATINGS
CITR: Fundamental Ratings
CITR
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
78
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CITRFEAM
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (CITR: $2.45 vs. FEAM: $1.81)
Brand notoriety: CITR and FEAM are both not notable
Both companies represent the Chemicals: Specialty industry
Current volume relative to the 65-day Moving Average: CITR: 83% vs. FEAM: 20%
Market capitalization -- CITR: $129.9M vs. FEAM: $79.55M
CITR [@Chemicals: Specialty] is valued at $129.9M. FEAM’s [@Chemicals: Specialty] market capitalization is $79.55M. The market cap for tickers in the [@Chemicals: Specialty] industry ranges from $50 to $237.52B. The average market capitalization across the [@Chemicals: Specialty] industry is $11.6B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CITR’s FA Score shows that 0 FA rating(s) are green while FEAM’s FA Score has 0 green FA rating(s).

  • CITR’s FA Score: 0 green, 5 red.
  • FEAM’s FA Score: 0 green, 5 red.
According to our system of comparison, FEAM is a better buy in the long-term than CITR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CITR’s TA Score shows that 5 TA indicator(s) are bullish while FEAM’s TA Score has 4 bullish TA indicator(s).

  • CITR’s TA Score: 5 bullish, 3 bearish.
  • FEAM’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CITR is a better buy in the short-term than FEAM.

Price Growth

CITR (@Chemicals: Specialty) experienced а +4.70% price change this week, while FEAM (@Chemicals: Specialty) price change was -19.20% for the same time period.

The average weekly price growth across all stocks in the @Chemicals: Specialty industry was -3.13%. For the same industry, the average monthly price growth was -3.39%, and the average quarterly price growth was -9.57%.

Reported Earning Dates

CITR is expected to report earnings on Nov 11, 2026.

FEAM is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Chemicals: Specialty (-3.13% weekly)

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

View a ticker or compare two or three
Interact to see
Advertisement

CITR and

Correlation & Price change

A.I.dvisor tells us that CITR and FSI have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CITR and FSI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CITR
1D Price
Change %
CITR100%
-5.04%
FSI - CITR
20%
Poorly correlated
N/A
ASPN - CITR
14%
Poorly correlated
-6.38%
FEAM - CITR
6%
Poorly correlated
-6.70%
LOOP - CITR
5%
Poorly correlated
-3.48%
LIN - CITR
4%
Poorly correlated
+0.28%
More

FEAM and

Correlation & Price change

A.I.dvisor tells us that FEAM and VHI have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FEAM and VHI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FEAM
1D Price
Change %
FEAM100%
-6.70%
VHI - FEAM
28%
Poorly correlated
+0.25%
LWLG - FEAM
27%
Poorly correlated
-10.59%
KOP - FEAM
26%
Poorly correlated
+0.95%
ESI - FEAM
24%
Poorly correlated
-0.64%
ASH - FEAM
23%
Poorly correlated
-1.15%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RSPF85.070.46
+0.54%
Invesco S&P 500 Equal Weight Financials ETF (RSPF)
RDIV62.530.22
+0.35%
Invesco S&P Ultra Dividend Revenue ETF (RDIV)
BIOY19.10-0.09
-0.47%
GraniteShares YieldBOOST Biotech ETF (BIOY)
GSJY51.70-0.71
-1.35%
Goldman Sachs ActiveBeta Japan Equity ETF (GSJY)
HOOG15.73-0.80
-4.87%
Leverage Shares 2X Long HOOD Daily ETF (HOOG)